OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Pieter Sonneveld, Thierry Façon, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 12, pp. e934-e946
Open Access | Times Cited: 33
Heinz Ludwig, Pieter Sonneveld, Thierry Façon, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 12, pp. e934-e946
Open Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
Scott Goldsmith, Fahrettin Covut, Mark A. Fiala, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 2
Scott Goldsmith, Fahrettin Covut, Mark A. Fiala, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 2
When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study
Xincheng Jiang, Xiaoyan Han, Fengyan Jin, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access
Xincheng Jiang, Xiaoyan Han, Fengyan Jin, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study
Niels W.C.J. van de Donk, Nizar J. Bahlis, Luciano J. Costa, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Niels W.C.J. van de Donk, Nizar J. Bahlis, Luciano J. Costa, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease
Qing He, Xuelin Dou, Yang Liu, et al.
Annals of Hematology (2023) Vol. 102, Iss. 10, pp. 2857-2864
Closed Access | Times Cited: 1
Qing He, Xuelin Dou, Yang Liu, et al.
Annals of Hematology (2023) Vol. 102, Iss. 10, pp. 2857-2864
Closed Access | Times Cited: 1
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation
Gianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, et al.
Infectious Agents and Cancer (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Gianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, et al.
Infectious Agents and Cancer (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 2
[Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases in China (2022)].
PubMed (2022) Vol. 43, Iss. 5, pp. 359-364
Closed Access | Times Cited: 1
PubMed (2022) Vol. 43, Iss. 5, pp. 359-364
Closed Access | Times Cited: 1
Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
João Bosco de Almeida, Inara Lúcia Arce, V.L.P. Figueiredo, et al.
Einstein (São Paulo) (2023) Vol. 31
Open Access
João Bosco de Almeida, Inara Lúcia Arce, V.L.P. Figueiredo, et al.
Einstein (São Paulo) (2023) Vol. 31
Open Access
